India is a key market for the company’s global plans EP News Bureau Aug 4, 2023 Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…
With oral Semaglutide, HCPs can provide robust HbA1c control to their type-II diabetes patients EP News Bureau Dec 2, 2022 Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…
Industry experts discuss regulatory roadmap for pharma industry Usha Sharma Oct 1, 2020 The stakeholders highlight the changes needed in the Indian regulatory system to meet changing demands, emerging concerns, at…
Novo Nordisk appoints Vikrant Shrotriya as MD, Corporate Vice President India EP News Bureau Jan 3, 2020 Shrotriya has worked in many national, international organisations in India, South East Asia and more recently in the GCC Novo…